FIELD: medicine, cardiology, neurology, rheumatology. SUBSTANCE: agent has the following composition, wt. -%: acetylsalicylic acid 28.70-38.70; polymer-carrier 22-32; glucose 22-32; calcium gluconate 2.20-3.20; lipophilic agent 7.60-8.60, and plasticizing agent - 1.00-2.00. Acetylsalicylic acid is immobilized on polymer-carrier. Agent is made as buccal medicinal formula. EFFECT: enhanced effectiveness of agent. 3 cl, 3 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTION OF PATIENTS WITH HIGH RISK OF EROSIVE-ULCEROUS ALTERATIONS OF GASTROINTESTINAL TRACT IN CASE OF ACETYLSALICYLIC ACID INTAKE | 2009 |
|
RU2405415C1 |
| METHOD OF TREATING PATIENTS WITH INFLAMMATORY DISEASES OF PARODENTIUM AND GUM | 2010 |
|
RU2445045C1 |
| METHOD FOR OBTAINING PREPARATION FOR DECREASING THROMBOCYTIC AGGREGATION IN CIRCULATORY SYSTEM | 2004 |
|
RU2252763C1 |
| METHOD FOR TREATING CARDIOVASCULAR DISEASES IN PATIENTS WITH EROSIVE-ULCEROUS LESIONS OF ESOPHAGO-GASTRODUODENAL AREA | 2002 |
|
RU2231357C2 |
| AGENT FOR FLUORESCENT DIAGNOSIS AND PHOTODYNAMIC THERAPY ON ONCOLOGICAL AND NON-ONCOLOGICAL DISEASES | 2002 |
|
RU2219921C1 |
| METHOD OF TREATMENT OF HYPERTENSION | 0 |
|
SU1393429A1 |
| METHOD FOR PATIENT-SPECIFIC SELECTION OF ANTIPLATELET DRUGS FOR PATIENTS IN NEED THEREOF | 2012 |
|
RU2499261C1 |
| AGENT FOR ANTIOXIDANT PROTECTION OF EYE MEDIA AND TISSUES | 1993 |
|
RU2070010C1 |
| METHOD OF REDUCING AGGREGATION ACTIVITY OF PLATELETS in vitro | 2009 |
|
RU2410104C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
